SCHEMBL14751476

SCHEMBL14751476

COC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C)c3)c(F)c2)ccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.64
BRAF P15056 8/20 0.64
MAPK14 Q16539 7/20 0.64
RAF1 P04049 5/20 0.64
RIPK2 O43353 3/20 0.64
FLT1 P17948 3/20 0.64
ABCB11 O95342 2/20 0.64
ABL1 P00519 2/20 0.64
RET P07949 2/20 0.64
HTR1A P08908 2/20 0.64
PDGFRB P09619 2/20 0.64
ADORA3 P0DMS8 2/20 0.64
KIT P10721 2/20 0.64
FGFR1 P11362 2/20 0.64
PDGFRA P16234 2/20 0.64
MAOA P21397 2/20 0.64
EPHA1 P21709 2/20 0.64
TBXA2R P21731 2/20 0.64
EPHA2 P29317 2/20 0.64
TTK P33981 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16851811 0.94 KDR (0.61) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL14751478 0.91 KDR (0.65) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL10105553 0.90 RAF1 (0.79) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL14680591 0.89 RAF1 (0.59) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL14752151 0.88 BRAF (0.61) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL12283302 0.88 KDR (0.66) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL12333608 0.88 RAF1 (0.82) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL14751419 0.87 KDR (0.70) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL14751440 0.81 RAB9A (0.62) KDRBRAFMAPK14RAF1RIPK2
SCHEMBL10105571 0.81 RAF1 (0.66) KDRBRAFMAPK14RAF1RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175545-A1 Preparation Method of Fluoro-Substituted Deuterated Diphenylurea SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) 2015-06-25 US disclosed
US-8759531-B2 Preparation method of fluoro-substituted deuterated diphenylurea Suzhou Zelgen Biopharmaccceutical Co., Ltd. (CN) 2014-06-24 US disclosed
US-20130060043-A1 PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD (CN) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130060043-A1 PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA CCND3, UBE2D3, VDR KDR 4466/4885BRAF 1533/4885MAPK14 3540/4885
US-20150175545-A1 Preparation Method of Fluoro-Substituted Deuterated Diphenylurea CCND3, UBE2D3, VDR KDR 4466/4885BRAF 1533/4885MAPK14 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.